At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PRCT PROCEPT BioRobotics
Post-Market Trading 10-24 16:14:43 EDT
66.83
-0.49
-0.73%
盘后66.83
+0.000.00%
16:01 EDT
High70.33
Low66.78
Vol795.19K
Open67.37
D1 Closing67.32
Amplitude5.27%
Mkt Cap3.47B
Tradable Cap3.31B
Total Shares51.93M
T/O54.02M
T/O Rate1.60%
Tradable Shares49.58M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Earnings Preview: Teleflex (TFX) Q3 Earnings Expected to Decline
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.